A new report describes a new simple molecular test to detect chromosomal abnormalities — biomarkers known as telomere fusions — in pancreatic tumor specimens and pancreatic cyst fluids. This assay may help predict the presence of high-grade or invasive pancreatic cancers requiring surgical intervention.